Fyteko Revenue and Competitors
Estimated Revenue & Valuation
- Fyteko's estimated annual revenue is currently $5.1M per year.
- Fyteko's estimated revenue per employee is $155,000
- Fyteko's total funding is $16M.
Employee Data
- Fyteko has 33 Employees.
- Fyteko grew their employee count by 27% last year.
Fyteko's People
| Name | Title | Email/Phone |
|---|
Fyteko Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $17.4M | 112 | 33% | N/A | N/A |
#2 | $1.1M | 7 | 0% | N/A | N/A |
#3 | $3.6M | 23 | 53% | $93.4M | N/A |
#4 | $5.4M | 35 | 13% | $38.9M | N/A |
#5 | $2.6M | 17 | -6% | $82.2M | N/A |
#6 | $5.1M | 33 | 27% | $16.4M | N/A |
#7 | $5.1M | 27 | 29% | $66.1M | N/A |
What Is Fyteko?
Founded in 2014 by visionary bio-entrepreneurs, Fyteko is a pioneer in sustainable agriculture innovation. By combining the power of nature with science, we develop advanced bio-based technologies that transform crop management.\n\nOur mission is to create biomolecules that protect and enhance the world’s crops while reducing agriculture's environmental impact. From biostimulants and herbicide bioenhancers to biocontrol solutions, our proprietary discoveries address the urgent need for sustainable and effective farming solutions.\n\nAt Fyteko, our multidisciplinary team of scientists and experts drives innovation through cutting-edge research, regulatory excellence, and product commercialization. Together, we are building a smarter, safer, and more sustainable agricultural future.\n\nWe call it the Science of Biopossible.
keywords:N/A
$16M
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Anderlecht
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.1M | 49 | 36% | N/A |
#2 | $10.7M | 58 | -41% | N/A |
#3 | $8.8M | 63 | 24% | N/A |
#4 | $13.4M | 84 | 25% | N/A |
#5 | $22.5M | 94 | 38% | N/A |